BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Down 91.7% in December

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totalling 4,400 shares, a drop of 91.7% from the November 30th total of 52,900 shares. Based on an average daily volume of 7,400 shares, the short-interest ratio is currently 0.6 days.

BioNxt Solutions Trading Up 14.9 %

BNXTF traded up $0.03 during trading on Friday, reaching $0.24. 1,400 shares of the company were exchanged, compared to its average volume of 4,860. The stock has a market cap of $27.67 million, a P/E ratio of -6.10 and a beta of 0.84. BioNxt Solutions has a 52 week low of $0.11 and a 52 week high of $0.57. The firm has a 50 day moving average of $0.20 and a 200 day moving average of $0.19.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.